TY - JOUR
T1 - Nanoparticles in medicine
T2 - Therapeutic applications and developments
AU - Zhang, L.
AU - Gu, F. X.
AU - Chan, J. M.
AU - Wang, A. Z.
AU - Langer, R. S.
AU - Farokhzad, O. C.
PY - 2008/5/30
Y1 - 2008/5/30
N2 - Nanotechnology is the understanding and control of matter generally in the 1-100 nm dimension range. The application of nanotechnology to medicine, known as nanomedicine, concerns the use of precisely engineered materials at this length scale to develop novel therapeutic and diagnostic modalities. 1,2 Nanomaterials have unique physicochemical properties, such as ultra small size, large surface area to mass ratio, and high reactivity, which are different from bulk materials of the same composition. These properties can be used to overcome some of the limitations found in traditional therapeutic and diagnostic agents.
AB - Nanotechnology is the understanding and control of matter generally in the 1-100 nm dimension range. The application of nanotechnology to medicine, known as nanomedicine, concerns the use of precisely engineered materials at this length scale to develop novel therapeutic and diagnostic modalities. 1,2 Nanomaterials have unique physicochemical properties, such as ultra small size, large surface area to mass ratio, and high reactivity, which are different from bulk materials of the same composition. These properties can be used to overcome some of the limitations found in traditional therapeutic and diagnostic agents.
UR - http://www.scopus.com/inward/record.url?scp=42349094203&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42349094203&partnerID=8YFLogxK
U2 - 10.1038/sj.clpt.6100400
DO - 10.1038/sj.clpt.6100400
M3 - Review article
C2 - 17957183
AN - SCOPUS:42349094203
SN - 0009-9236
VL - 83
SP - 761
EP - 769
JO - Clinical pharmacology and therapeutics
JF - Clinical pharmacology and therapeutics
IS - 5
ER -